| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | CITRULLINE-C13 Basic information |
| Product Name: | CITRULLINE-C13 | | Synonyms: | CITRULLINE-C13;(2S)-2-amino-5-(aminocarbonylamino)pentanoic acid;L-Citrulline-13C;L-Citrulline-13C (Standard) | | CAS: | 94740-46-2 | | MF: | C6H13N3O3 | | MW: | 176.18 | | EINECS: | | | Product Categories: | | | Mol File: | 94740-46-2.mol |  |
| | CITRULLINE-C13 Chemical Properties |
| density | 1.289±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | storage temp. | Store at -20°C | | form | Solid | | color | White to off-white | | CAS Number Unlabeled | 372-75-8 |
| | CITRULLINE-C13 Usage And Synthesis |
| Uses | L-Citrulline-13C is the 13C-labeled L-Citrulline. L-Citrulline is an amino acid derived from ornithine in the catabolism of proline or glutamine and glutamate, or from l-arginine via arginine-citrulline pathway. | | Definition | ChEBI: L-citrulline is the L-enantiomer of citrulline. It has a role as an EC 1.14.13.39 (nitric oxide synthase) inhibitor, a protective agent, a nutraceutical, a micronutrient, a human metabolite, an Escherichia coli metabolite, a Saccharomyces cerevisiae metabolite and a mouse metabolite. It is an enantiomer of a D-citrulline. It is a tautomer of a L-citrulline zwitterion. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110 |
| | CITRULLINE-C13 Preparation Products And Raw materials |
|